β¨ Medicines Notices
7 MARCH
NEW ZEALAND GAZETTE
593
Product:
Sensodyne Dual Protection - (Fresh Mint with Fluoride)
Active Ingredient(s):
Potassium nitrate 5%w/w
Sodium monofluorophosphate 0.76%w/w
Triclosan 0.3%w/w
Dosage Form:
Toothpaste
New Zealand Sponsor:
Stafford-Miller (NZ) Limited
Manufacturer:
Stafford-Miller (Ireland) Limited, Dungarvan, Co. Waterford, Eire
Product:
Sensodyne Dual Protection - (Gentle Whitening with Fluoride)
Active Ingredient(s):
Potassium nitrate 5%w/w
Sodium fluoride 0.221%w/w
Triclosan 0.3%w/w
Dosage Form:
Toothpaste
New Zealand Sponsor:
Stafford-Miller (NZ) Limited
Manufacturer:
Stafford-Miller (Ireland) Limited, Dungarvan, Co. Waterford, Eire
Dated this 28th day of February 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go1535
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Celebrex
Active Ingredient:
Celecoxib 100mg
Dosage Form:
Capsule
New Zealand Sponsor:
Pharmacia Limited Company trading as Pharmacia
Manufacturer:
Searle Limited, Caguas, Puerto Rico
Product:
Celebrex
Active Ingredient:
Celecoxib 200mg
Dosage Form:
Capsule
New Zealand Sponsor:
Pharmacia Limited Company trading as Pharmacia
Manufacturer:
Searle Limited, Caguas, Puerto Rico
Product:
Minirin
Active Ingredient:
Desmopressin acetate 0.1mg equiv to 0.089mg free base
Dosage Form:
Tablet
New Zealand Sponsor:
Pharmaco (NZ) Limited
Manufacturer:
PolyPeptide Laboratories AB, Limhamm, Sweden
Product:
Minirin
Active Ingredient:
Desmopressin acetate 0.2mg equiv to 0.178mg free base
Dosage Form:
Tablet
New Zealand Sponsor:
Pharmaco (NZ) Limited
Manufacturer:
PolyPeptide Laboratories AB, Limhamm, Sweden
Product:
Zoladex 3.6mg
Active Ingredient:
Goserelin acetate 3.6mg
Dosage Form:
Subcutaneous implant
New Zealand Sponsor:
AstraZeneca Limited
Manufacturer:
AstraZeneca UK Limited, Macclesfield, Cheshire, United Kingdom
Dated this 28th day of February 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go1534
Classification of Medicines
Pursuant to section 106 (1) of the Medicines Act 1981,
I, G. R. Boyd, Chief Advisor, Public Health Directorate,
acting under delegated authority, hereby declare the following:
-
The medicines listed in Schedule 1 to this notice are classified as prescription medicines.
-
The medicines listed in Schedule 2 to this notice are classified as restricted medicines.
-
The medicines listed in Schedule 3 to this notice are classified as pharmacy-only medicines.
Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2002, No 20
Gazette.govt.nz —
NZ Gazette 2002, No 20
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare28 February 2002
Medicines Act 1981, Sensodyne Dual Protection, New Medicines, Distribution Consent
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social Welfare28 February 2002
Medicines Act 1981, Celebrex, Minirin, Zoladex, Changed Medicines, Distribution Consent
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Classification of Medicines
π₯ Health & Social WelfareMedicines Act 1981, Prescription Medicines, Restricted Medicines, Pharmacy-Only Medicines, Classification
- G. R. Boyd, Chief Advisor, Public Health Directorate